Diploma plc (DPLM.L) — Company Research

Last Updated: 8 May 2026

Diploma plc is a London-listed and London-headquartered specialist industrial distributor that operates through three business sectors — Controls, Seals and Life Sciences — across the United Kingdom, Continental Europe, North America and other international markets. The Controls sector supplies wire, cabling, interconnect, specialty fasteners, specialty adhesives and industrial-automation components; the Seals sector supplies sealing products, fluid-power products, gaskets, hoses and fittings, pumps and valves into aftermarket repair, original-equipment-manufacturing and maintenance/repair/overhaul channels; and the Life Sciences sector supplies and services equipment, consumables and instrumentation for surgery, disease diagnosis, critical-care support, endoscopy, surgical instruments and clinical nutrition into public and private hospitals, clinics and diagnostics laboratories. The shares trade on the London Stock Exchange in pence (DPLM.L), the company reports its accounts in pounds sterling, and the most recent fiscal year ended 30 September 2025. FY2025 reported revenue rose 11.8% year-on-year, operating income rose 37.8%, and diluted EPS rose 42.9%. During the second quarter of the current fiscal year (FY2026), management hosted a conference call on 18 March 2026 in which CEO Johnny Thomson upgraded full-year organic-growth guidance to 6%–9% and operating-margin guidance to 25%, citing a "very strong" first half. This research note assembles the financials, the segment description, the news flow and the on-calendar events using only Diploma's reported data and the primary news sources captured in the report's source dataset, with no analyst opinions or price targets included.

1. Company Snapshot

Name	Diploma plc
Ticker	DPLM.L (London Stock Exchange)
Sector / Industry	Industrials / Industrial Distribution
Country of incorporation	United Kingdom
Reporting currency	Pound sterling (GBP)
Market cap	£9.43 billion
Enterprise value	£9.82 billion
Latest fiscal-year revenue	£1,524.5 million (FY2025, ended 30 September 2025)
Employees	3,390
CEO	Mr. Jonathan David ("Johnny") Thomson
Headquarters	10-11 Charterhouse Square, London, United Kingdom
Website	diplomaplc.com
Price (intraday 8 May 2026)	7,035.0p
Previous close	7,225.0p
52-week high	7,225.0p
52-week low	not disclosed in this report's source data (the field is logged as 0.0p in the underlying dataset, which is not credible and is therefore omitted here)

2. Bull Case vs Bear Case

Bull case

• Revenue growth has been strong and consistent: £1,012.8m (FY2022) → £1,200.3m (FY2023, +18.5%) → £1,363.4m (FY2024, +13.6%) → £1,524.5m (FY2025, +11.8%). Each of the last three reported fiscal years has produced double-digit reported revenue growth.
• FY2025 delivered material profit-line operating leverage: gross profit rose to £706.1m (gross margin 46.32%), operating income rose 37.8% from £206.8m to £284.9m (operating margin 18.69%), and net income rose 43.0% from £129.3m to £184.9m. Diluted EPS jumped 42.9%, from £0.961 to £1.373.
• Management upgraded FY2026 guidance on 18 March 2026 in a conference call led by CEO Johnny Thomson, lifting organic-growth expectations to 6%–9% and operating-margin guidance to 25%, citing a "very strong" first half (per the recent_news entries, MarketBeat, 18 March 2026; and Moby, 18 March 2026).
• Free cash flow has stepped up year-on-year for three consecutive reporting periods: £166.1m (FY2023), £178.4m (FY2024), £253.2m (FY2025). FCF covered the FY2025 dividend (£80.7m paid) more than three times over.
• Capital intensity is genuinely low. Capex was £14.4m in FY2025 against revenue of £1,524.5m — under 1% of revenue — consistent with the asset-light specialist-distribution business model.
• Liquidity and balance sheet are healthy: current ratio of 2.04×, debt-to-equity of 0.47×, cash and equivalents of £81.7m, and total equity of £989.7m at FY2025 year-end. Total debt fell from £552.1m at FY2024 year-end to £464.9m at FY2025 year-end.
• Beta of 0.92 reflects a historically lower-than-market sensitivity to broad equity-index moves, consistent with the diversified industrial-distribution mix across Controls, Seals and Life Sciences.
• The CEO has put personal capital to work: Johnny Thomson reported a 30,000-share purchase on 16 January 2026 at an aggregate value of £2,275,290 (an implied price of approximately 7,584p per share), a discretionary purchase rather than a register-disclosure filing.

Bear case

• The headline trailing P/E quoted in the underlying dataset is mathematically broken (5,123.82× is the result of dividing the LSE pence-quoted price by the GBP-denominated diluted EPS without unit conversion). The currency-normalised trailing P/E from yfinance is 51.35×, which is itself a high multiple in absolute terms relative to the wider UK industrials sector.
• Forward P/E (yfinance) sits at 30.24×, still a premium multiple — a meaningful portion of the upgraded earnings trajectory is already priced in.
• Price-to-book of 9.53× and price-to-sales of 6.19× are elevated multiples for an industrial distributor. EV/Revenue of 6.44× is similarly elevated relative to the sector.
• The current price of 7,035.0p sits 2.63% below the previous close of 7,225.0p (which is also the 52-week high logged in the dataset), reflecting recent share-price weakness against the multi-year trend.
• Dividend yield is modest at 0.87%, meaning capital-return-driven total return is dependent on share-price appreciation rather than running cash yield. The total dividend-paid figure was £80.7m in FY2025 versus FY2025 free cash flow of £253.2m — a 3.1× coverage ratio, but the absolute yield to shareholders at the current price is low.
• Inventory and working-capital exposure are not separately disclosed in this report's source data; specialty-distribution businesses are inherently working-capital intensive in absolute terms even when capex is low.
• The recent_news flow includes multiple third-party valuation pieces (Simply Wall St., dated 5 May 2026, 7 March 2026, 6 February 2026, 21 January 2026, 20 January 2026, 4 January 2026) that the article does not summarise per the no-analyst-opinion rule, but their frequency is itself evidence of an actively re-rated and re-modelled stock — sensitivity to discount-rate or growth-assumption changes is correspondingly high.
• The report's source data does not include a parsed Annual Report or Form 20-F (Diploma is a UK filer and does not file with the SEC, so a 10-K equivalent is not available in the dataset). Segment-level revenue and operating-profit splits between Controls, Seals and Life Sciences — and the geographic split — are therefore not directly quoted in this article. Investors needing that breakdown should consult the company's most recent Annual Report directly via diplomaplc.com.

3. What Does This Company Actually Do?

Diploma plc is a specialist technical-products and -services distributor. It does not, in the main, manufacture the underlying products it sells; it acquires them from upstream OEMs and producers and distributes them to industrial, commercial, healthcare and OEM customers, taking margin on technical specification, engineering support, application know-how, breadth of stocked SKUs, and the cost of holding inventory close to the customer's point of use.

The group reports through three sectors:

• Controls — wire and cabling, interconnect components, specialty fasteners, specialty adhesives and industrial-automation solutions for use in machinery, transportation, energy, defence and other industrial applications.
• Seals — sealing products, fluid-power components, gaskets, hoses and fittings, pumps and valves. The customer mix spans aftermarket repair, original-equipment manufacturing (OEM), and maintenance/repair/overhaul (MRO) workflows.
• Life Sciences — equipment supply and service plus consumables and instrumentation for surgery, disease diagnosis and critical-care support; the product set extends to diagnostic and scientific technologies, surgical instruments, medical devices, endoscopes, patient-monitoring equipment, specialist hospital supplies and clinical nutrition. Customers are public and private hospitals, clinics and diagnostics laboratories.

Specific revenue and operating-profit splits between the three sectors — and the further breakdown by geography (UK, Continental Europe, North America, international) — are typically disclosed in Diploma's Annual Report. The report's source data does not contain a parsed Annual Report extract for Diploma (the SEC sec_filings array is empty because Diploma is a UK filer rather than a U.S.-domiciled or U.S.-cross-listed reporting company), so segment percentages are not quoted here. Readers seeking that breakdown should consult the most recent Annual Report directly via the company's investor-relations site at diplomaplc.com. With fewer than two segment percentages available in the source data, the Revenue Mix donut visualisation has been omitted.

The company was incorporated in 1999 and is headquartered at 10-11 Charterhouse Square, London. As of the dataset capture, it employed 3,390 people across its operations.

4. The Business Model

Diploma operates a "buy-and-build" specialist-distribution model that combines (i) a stable installed base of industrial, OEM and healthcare customers buying low-ticket but mission-critical specialist consumables; with (ii) a long-running programme of bolt-on acquisitions that adds new product lines, new geographies and new vertical end-markets to the existing distribution platform. The unit economics are characterised by relatively high gross margin for a distributor (because the products are technical, often custom-spec, and command price for application engineering rather than for raw bulk), modest absolute gross-profit pounds per shipment, and very low capex intensity.

Margin profile. In FY2025 (year ended 30 September 2025) Diploma reported revenue of £1,524.5m and gross profit of £706.1m — a gross margin of 46.32%. Operating income was £284.9m (operating margin 18.69%) and net income was £184.9m (net margin 12.13%). By comparison, FY2024 had operating margin of 15.17% (£206.8m on £1,363.4m revenue) and FY2023 had operating margin of 15.48% (£185.8m on £1,200.3m). Operating margin therefore expanded by approximately 350 basis points from FY2024 to FY2025 — a structurally meaningful improvement, consistent with the management commentary referenced in the 18 March 2026 trading update which lifted the FY2026 operating-margin guide to 25% (per the recent_news entry, MarketBeat, 18 March 2026).

The moat. In specialist distribution the principal observable barriers to entry are technical depth (the salesforce must understand the application — e.g. the right elastomer for a specific seal in a specific fluid in a specific OEM), supplier relationships (often exclusive territory rights with European or U.S. specialty manufacturers), the cost of carrying broad inventory close to customers, and customer switching cost (a customer running a critical line that depends on a specific specified part will not casually re-tender for a marginal price saving). These features, layered across hundreds or thousands of low-volume product lines, produce a "long tail" of resilient demand that does not move tightly with the broad industrial cycle. Diploma's growth has historically been driven by (a) organic sales growth in the existing product lines and (b) the acquisition of additional regional or product-niche distributors that fit into one of the three sector platforms.

Capital intensity. Capex was £14.4m in FY2025 (0.94% of revenue), £19.7m in FY2024 (1.45%) and £23.1m in FY2023 (1.92%). Operating cash flow was £267.6m in FY2025 (a step-up from £198.1m in FY2024 and £189.2m in FY2023), and free cash flow was £253.2m, £178.4m and £166.1m in those three years respectively. The combination of high gross margin, low maintenance capex, and moderate working-capital intensity produces a relatively clean cash-conversion profile and supports both the dividend and the bolt-on acquisition pipeline.

Government incentives, regulatory credits and subsidy dependency. Diploma's revenue is principally derived from commercial-and-industrial product distribution and from Life Sciences supplies into hospitals and laboratories. Healthcare-segment revenue may be exposed indirectly to public-healthcare-budget cycles in the UK (NHS), Continental Europe and North America, but the report's source data does not quantify any direct subsidy, tax-credit or regulatory-credit revenue stream. Specific quantification of this exposure would require the company's Annual Report and is not in this report's source data.

5. Financial Health

Four-year P&L, balance-sheet and cash-flow trend (GBP millions; fiscal year ends 30 September)

Fiscal year	FY2022	FY2023	FY2024	FY2025
Revenue	£1,012.8	£1,200.3	£1,363.4	£1,524.5
Gross profit	£144.3*	£542.3	£628.9	£706.1
Operating income	£144.3	£185.8	£206.8	£284.9
Net income	£94.7	£117.7	£129.3	£184.9
EPS (diluted, £)	£0.759	£0.904	£0.961	£1.373
Operating cash flow	£125.0	£189.2	£198.1	£267.6
Capex	£(15.4)	£(23.1)	£(19.7)	£(14.4)
Free cash flow	£109.6	£166.1	£178.4	£253.2
Dividends paid	£(56.2)	£(70.5)	£(76.8)	£(80.7)
Diluted share count (mn)	124.9	130.3	134.5	134.7
Total debt	£439.7	£397.3	£552.1	£464.9
Long-term debt	£340.1	£316.8	£479.8	£380.2
Cash & equivalents	£41.7	£62.4	£55.5	£81.7
Total equity	£662.0	£895.6	£888.0	£989.7
Total assets	£1,379.0	£1,589.3	£1,772.1	£1,809.4

*Note on FY2022 P&L breakdown: the report's source data records gross profit of £144.3m on revenue of £1,012.8m for FY2022, equal to operating income of £144.3m for the same year. The two figures being identical implies the cost-of-revenue / operating-expense split has been categorised differently in that year's underlying dataset, and the 14.2% implied gross-margin rate is not consistent with the 45–46% gross-margin rate that prevails in FY2023, FY2024 and FY2025. Readers should treat the FY2022 gross-profit and cost-of-revenue lines as data-quality-flagged in this dataset; the operating-income, net-income and cash-flow lines for FY2022 remain quotable. The FY2021 line is omitted from the table above because almost all FY2021 fields are null in the source data.

The trajectory of the business across the three clean years (FY2023 → FY2025) is a steady step-up in absolute scale combined with a step-up in unit profitability. Revenue compounded at roughly 12.6% per annum from £1,200.3m to £1,524.5m. Gross profit compounded faster, from £542.3m to £706.1m. Operating income compounded faster still, from £185.8m to £284.9m — an increase of 53% over two years, with margin expansion of about 320 basis points. Net income rose from £117.7m to £184.9m, a 57% increase. Diluted EPS rose from £0.904 to £1.373, a 52% increase, with the diluted share count drifting up only modestly from 130.3m to 134.7m as the bolt-on acquisition programme issued small parcels of equity for tuck-in deals.

The cash-flow-statement profile for the same window shows cleanly compounding cash generation: operating cash flow £189.2m → £198.1m → £267.6m, capex £23.1m → £19.7m → £14.4m, and free cash flow £166.1m → £178.4m → £253.2m. The £253.2m FY2025 FCF figure equates to a free-cash-flow yield of 2.68% on the current £9.43 billion market cap — modest in absolute terms because the share-price multiple is high.

The balance sheet has expanded but remains conservatively geared. Total debt at FY2025 year-end of £464.9m versus total equity of £989.7m gives a debt-to-equity of 0.47×; net debt of approximately £383.2m (£464.9m total debt less £81.7m cash) is around 1.34× FY2025 operating income. The current ratio of 2.04× indicates more than two pounds of current assets per pound of current liabilities. FY2025 interest expense was £25.7m, equivalent to about 9% of operating income — a comfortable interest-cover ratio.

The report's source data does not contain quarterly P&L data for Diploma (the company reports interim results at H1 and full-year results at year-end, supplemented by trading updates), so the quarterly Revenue + Gross Margin chart has been omitted.

6. Valuation & Market Data

All figures as of intraday 8 May 2026 unless dated otherwise. Price metrics are quoted in pence (GBp) reflecting the LSE listing convention; Diploma reports financials in pounds sterling.

Metric	Value
Price	7,035.0p
Previous close	7,225.0p
Day open	7,230.0p
Day high / low	not disclosed in this report's source data
52-week high	7,225.0p
52-week low	not disclosed in this report's source data (logged as 0.0p in the dataset)
Market cap	£9.43 billion
Enterprise value	£9.82 billion
Shares outstanding	134,094,839
Float	133,036,831
Beta	0.917
Trailing P/E (yfinance, currency-normalised)	51.35
Forward P/E (yfinance)	30.24
P/B	9.53
P/S (trailing)	6.19
EV / Revenue	6.44
EV / Operating income (proxy for EV/EBITDA)	34.47
FCF yield	2.68%
Dividend yield	0.87%
Volume (intraday at 05:00 UTC capture)	0 shares (capture was pre-market open)
10-day average volume	691,308 shares
Short interest (shares short, % of float, days to cover)	not disclosed in this report's source data
Put/call ratio	not disclosed in this report's source data

A note on the trailing P/E. The report's underlying ratio table contains an arithmetically computed pe_trailing of 5,123.82, which is the result of dividing the LSE pence-quoted price (7,035.0) by the GBP-denominated diluted EPS (£1.373) without unit conversion. That figure is not currency/unit-consistent and is therefore not used as the headline P/E above; the 51.35× trailing-P/E figure quoted in the table is the cross-currency-normalised yfinance value, which is internally consistent with the share price and the diluted EPS once the £1.373 EPS is restated as 137.3p (7,035p / 137.3p ≈ 51.24×, within rounding of 51.35).

The forward P/E of 30.24× sits well below the trailing 51.35× and reflects the market's expectation that the FY2025 earnings step-up extends into FY2026; the 18 March 2026 management upgrade to 6%–9% organic growth and 25% operating margin (per the recent_news entries, MarketBeat, 18 March 2026; and Moby, 18 March 2026) is consistent with that pricing.

A note on EV/EBITDA: the source data provides an EV/operating-income proxy of 34.47× because depreciation & amortisation are not separately disclosed in the snapshot; adding D&A back would lower the genuine EV/EBITDA multiple. The EV/Revenue ratio of 6.44× is high for a distributor and reflects the unusually wide gross-margin profile (46.32%) that Diploma generates relative to the sector.

7. What Are They Building / What's Coming?

The report's source data does not include a parsed Annual Report extract for Diploma (the SEC sec_filings array is empty because Diploma is not a U.S.-cross-listed filer). The company's own forward statements about acquisition pipeline, capital-allocation priorities, sector-platform expansions and innovation pipeline are therefore not directly quoted from a 10-K or 20-F here. Readers seeking that disclosure should consult the most recent Annual Report directly at diplomaplc.com.

What is captured directly from the news flow in the report's source dataset:

• 18 March 2026 — FY2026 outlook upgrade. Diploma upgraded its full-year trading expectations during a conference call led by CEO Johnny Thomson, citing a "very strong" first half and confidence in momentum into the second half. Management raised organic-growth guidance to 6%–9% and lifted operating-margin guidance to 25% (per the recent_news entries, MarketBeat, 18 March 2026; and Moby, 18 March 2026). Acquisition-driven growth expectations were left at the previously communicated level per the MarketBeat summary.
• 14 January 2026 — Q1 FY2026 trading update. Diploma reported a strong start to its financial year in a first-quarter trading update. CEO Johnny Thomson highlighted "double-digit organic growth" and continued momentum on acquisitions; management noted the Q1 update was the first delivered alongside newly promoted CFO Wilson (per the recent_news entry, MarketBeat, 14 January 2026).
• CEO open-market share purchase, 16 January 2026. Two trading days after the Q1 update, the report's source data records a 30,000-share purchase by Jonathan David ("Johnny") Thomson at an aggregate value of £2,275,290 — an implied price of approximately 7,584p per share. This is a discretionary purchase rather than a TR-1-style register-disclosure filing.

The company does not, in the report's source data, disclose AI-infrastructure investments, supercomputers or custom-silicon programmes — Diploma is not a technology platform but a specialist industrial distributor, and capex is concentrated in distribution-network capacity, IT systems, and tuck-in M&A integration. Specific named acquisitions completed in the FY2026 first half are not enumerated in the source dataset; the management commentary on the 18 March 2026 call referenced ongoing acquisition momentum but did not list the deals individually in the captured news entries.

8. Competitive Landscape

Diploma competes in three structurally different end-markets — Controls (industrial cabling, fasteners, automation), Seals (fluid power, sealing) and Life Sciences (medical equipment and consumables) — against a different competitor set in each. The competitive set below is illustrative of the public-listed peers that operate in the same specialist-distribution channels.

Operator	Listing / origin	Where they compete with Diploma
RS Group plc (formerly Electrocomponents)	LSE (RS1.L), United Kingdom	Industrial and electronic components distribution — overlap with Diploma's Controls sector across cabling, interconnect and industrial-automation product lines.
DCC plc	LSE (DCC.L), Ireland/UK	UK-listed distribution conglomerate; structurally different mix (energy and technology distribution) but comparable as a UK industrials peer in the broader specialist-distribution category.
Bunzl plc	LSE (BNZL.L), United Kingdom	Specialist non-food distribution to a wide range of B2B end markets — UK-listed comparator on the buy-and-build distribution model.
Halma plc	LSE (HLMA.L), United Kingdom	Acquisitive UK-listed specialist-products group with a similar bolt-on acquisition strategy and similar premium valuation profile; overlap with Diploma's Life Sciences sector through certain medical-device niches.
Watsco, Inc.	NYSE (WSO), United States	HVAC/R products distribution at scale in North America — illustrative U.S.-listed peer on the specialist-distribution model rather than a direct product-line competitor.
Hayward Industries / regional Seals OEMs and distributors	Various	Sealing and fluid-power competitors at the regional and product-line level; the global sealing distribution market is fragmented, with Diploma owning a position through brands within its Seals sector.
Independent regional industrial distributors (private)	Various	The cabling, fastener, sealing and Life Sciences distribution markets in the UK, Continental Europe and North America are populated by hundreds of regional private operators; Diploma's growth has historically come from acquiring such operators into the three sector platforms.

Specific market-share percentages by category and by region for Diploma and its competitors are typically disclosed in Diploma's Annual Report rather than in the dataset underlying this note; named market shares for at least three competitors are not available in this report's source data, so the Competitor Share visualisation has been omitted.

The competitive pattern that emerges is that Diploma is itself a consolidator in specialist industrial-and-medical distribution. It runs three sector platforms (Controls, Seals, Life Sciences) into which it bolts on regional and product-niche distributors, rather than competing head-to-head with the largest broad-line industrial distributors on price. The premium valuation multiple (forward P/E of 30.24×, EV/Revenue of 6.44×) is consistent with the market pricing Diploma alongside other UK-listed acquisitive specialist-products groups (Halma, Bunzl) rather than alongside lower-multiple broad-line industrial distributors.

9. Leadership and Ownership

CEO and management. The report's source data lists the chief executive as Mr. Jonathan David ("Johnny") Thomson. The company's headquarters is at 10-11 Charterhouse Square, London. Detailed biographies of the executive team and the wider board are typically disclosed in the company's Annual Report and are not parsed in the dataset underlying this note. Specific tenure or age information for the CEO is not captured in this report's source data and is therefore not stated here. The 14 January 2026 Q1 trading update also referenced the recent CFO appointment of "newly promoted CFO Wilson" (per the recent_news entry, MarketBeat, 14 January 2026); a more detailed biographical record of the CFO is not in the captured dataset.

Workforce. As of the dataset capture, the company employed 3,390 people across its global operations.

Top reported holders. The institutional-holders list captured in this dataset is sparse — only one holder line is recorded (Hurley Capital, LLC, 176 shares as of 31 December 2024, equivalent to a vanishingly small fraction of shares outstanding). The principal U.K. shareholder register (held in CREST and visible primarily through annual disclosures and major-shareholder notifications under the FCA Disclosure Guidance and Transparency Rules) is not parsed in this report's source data. The headline ownership picture is therefore not cleanly visible from this dataset alone.

Recent insider and register-disclosure filings. The report's source data records a mix of TR-1-style register-disclosure entries from major institutional holders and a smaller set of PDMR (Person Discharging Managerial Responsibility) trades by directors. The entries are reported verbatim from the source data; for the institutional rows, the position/transaction direction is not captured and is therefore left blank. For the director entries, where a transaction value is recorded, that value is shown.

Date	Reporting entity / individual	Shares	Reported value	Type
2026-04-16	Norges Bank	84,098	—	Institutional / register disclosure
2026-04-07	Capital Group Companies, Inc.	1,526,481	—	Institutional / register disclosure
2026-03-20	El-mokadem (Ian)	500	£38,816	Director / PDMR-style
2026-03-20	BlackRock Advisors (UK) Limited	29,629	—	Institutional / register disclosure
2026-03-19	Bickerstaffe (Katie)	251	£19,972	Director / PDMR-style
2026-03-19	Huse (Geraldine)	535	£41,917	Director / PDMR-style
2026-01-23	Capital Group Companies, Inc.	75,819	—	Institutional / register disclosure
2026-01-16	Thomson (Jonathan David) — CEO	30,000	£2,275,290	Director / discretionary purchase (CEO)
2026-01-14	Bickerstaffe (Katie)	352	£26,701	Director / PDMR-style
2026-01-14	El-mokadem (Ian)	500	£37,727	Director / PDMR-style

The CEO's 30,000-share purchase on 16 January 2026 — at an aggregate value of £2,275,290 (an implied price of approximately 7,584p per share) — is the largest single discretionary trade in the captured insider window and was logged two trading days after the 14 January 2026 Q1 trading update. The report's source data does not include 10b5-1 plan flags on these trades; under U.K. share-dealing-policy convention, director trades occurring inside an open trading window would normally be reported under the company's own share-dealing code rather than under a U.S.-style 10b5-1 plan.

The two repeated Capital Group entries (1,526,481 shares on 7 April 2026 and 75,819 shares on 23 January 2026) and the BlackRock Advisors (UK) Limited entry on 20 March 2026 are characteristic of TR-1 / DTR 5 disclosure filings — i.e. notifications of changes in the holder's percentage interest crossing a disclosure threshold rather than discretionary insider trades.

Capital return. Diploma paid £80.7m of dividends in FY2025 (versus £76.8m in FY2024, £70.5m in FY2023 and £56.2m in FY2022). The report's source data does not record share buybacks for FY2025, FY2024, FY2023 or FY2022 (the stock_buybacks field is null or zero throughout this window — a -£0.6m entry exists for FY2021 only). The dividend yield based on the current 7,035.0p price is 0.87%.

10. Risks and Challenges

Risk-factor narrative is typically disclosed in Diploma's Annual Report. The report's source data does not include a parsed Annual Report extract for Diploma (the sec_filings array is empty because Diploma does not file a Form 10-K or 20-F with the U.S. SEC), so the section heading material below is grounded in the financial figures and news flow already cited rather than in the company's own risk-factor language. Readers seeking the company's own articulated risks should consult the most recent Annual Report directly via diplomaplc.com. The full risk-factor content is not cleanly available from this report's source data.

The principal observable risks in the dataset are:

• Premium valuation multiple. The currency-normalised trailing P/E of 51.35× and forward P/E of 30.24× — combined with EV/Revenue of 6.44× and price-to-book of 9.53× — leave the share price exposed to multiple compression in the event of any disappointment relative to the upgraded FY2026 guidance (6%–9% organic growth, 25% operating margin per the 18 March 2026 update; per the recent_news entries, MarketBeat, 18 March 2026; and Moby, 18 March 2026).
• Industrial-cycle sensitivity. The Controls and Seals sectors sell into industrial OEM and aftermarket end-markets that are sensitive to capital expenditure, MRO budgets and broader industrial-production cycles in the UK, Continental Europe and North America. A coordinated downturn in industrial spending would compress the same operating leverage that drove the FY2024 → FY2025 margin expansion in the opposite direction.
• Healthcare-budget exposure. The Life Sciences sector is exposed to public-sector healthcare-budget cycles, NHS procurement frameworks and equivalents in Continental Europe and North America. Specific quantification of this exposure is not in the report's source data.
• Acquisition-integration risk. Diploma's growth model depends on acquiring regional or product-niche distributors and integrating them into the three sector platforms. Acquisition-integration always carries execution risk; a single large mis-priced or mis-integrated deal could damage segment unit economics for several reporting periods. Specific named FY2026 acquisitions are not enumerated in the source dataset.
• Working-capital and inventory exposure. Specialty distribution requires holding broad inventory close to the customer's point of use. The report's source data does not separately disclose working-capital line items (inventory, receivables, payables), but a sustained slowdown in customer order rates can absorb cash quickly through inventory build.
• FX translation. Diploma reports in GBP but earns substantial revenue in USD (North America), EUR (Continental Europe) and other currencies. FX swings translate directly into reported revenue and operating profit; a strengthening pound would compress reported growth.
• Dependence on a small number of large-supplier relationships. Specialist distribution typically depends on exclusive territory rights with a manageable number of upstream OEMs/manufacturers. Loss of a single large supplier line — or a pivot by an OEM toward direct distribution — would materially alter the segment mix. The report's source data does not disclose customer or supplier concentration.
• Sparse U.S.-style disclosure data in the dataset. The report's source data captures only one institutional holder line, has no parsed Annual Report or 20-F extract, and the 52-week-low field is logged as 0.0p (which is not credible). Investors using this dataset alone will have an incomplete picture of free-float dynamics, segment splits and risk-factor narrative — Diploma's primary disclosure regime is the FCA Disclosure Guidance and Transparency Rules and the company's own Annual Report, both of which sit outside the underlying dataset.
• CEO and CFO transition. The 14 January 2026 Q1 trading update referenced "newly promoted CFO Wilson" delivering the update alongside CEO Johnny Thomson (per the recent_news entry, MarketBeat, 14 January 2026). New CFO transitions sometimes coincide with accounting-policy reviews; the FY2026 H1 results announcement scheduled for 19 May 2026 is the first full set of results delivered with the new CFO and is therefore informationally important.

11. Recent Developments

The most recent items first; URLs are taken verbatim from the report's source recent_news[].

• 5 May 2026 — How The Diploma (LSE:DPLM) Story Is Shifting With New Targets And Updated Growth Assumptions (Simply Wall St.). Third-party analytical commentary on the company's valuation inputs; the article does not summarise the substance per the no-analyst-opinion rule. (https://finance.yahoo.com/markets/stocks/articles/diploma-lse-dplm-story-shifting-061047845.html)
• 18 March 2026 — Diploma Upgrades FY Outlook After "Very Strong" H1, Lifts Organic Growth to 6%–9% and Margins to 25% (MarketBeat). Diploma (LON:DPLM) upgraded its full-year trading expectations during a conference call led by CEO Johnny Thomson, citing a "very strong" first half and confidence in momentum into the second half. Management raised organic-growth guidance to 6%–9%, while leaving acquisition-driven growth expectations at the previously communicated level. (https://www.marketbeat.com/instant-alerts/diploma-upgrades-fy-outlook-after-very-strong-h1-lifts-organic-growth-to-69-and-margins-to-25-2026-03-18/?utm_source=yahoofinance&utm_medium=yahoofinance)
• 18 March 2026 — Diploma's Upgrade Shows Why Boring Industrial Stocks Still Win (Moby). Coverage of the same 18 March 2026 outlook upgrade; the UK distributor lifted growth and margin targets after a strong first half. (https://app.moby.co/home/news/news-diplomas-upgrade-shows-why-boring-industrial-stocks-still-win?utm_source=yahoo_finance&utm_medium=rss)
• 7 March 2026 — How The Diploma (LSE:DPLM) Valuation Story Is Shifting On Execution And Analyst Assumptions (Simply Wall St.). Third-party valuation commentary; not summarised here per the no-analyst-opinion rule. (https://finance.yahoo.com/news/diploma-lse-dplm-valuation-story-091142712.html)
• 5 March 2026 — Royce International Premier Fund Exits JTC PLC, Impacting Portfolio by -3.05% (GuruFocus.com). Coverage of Q4 2025 portfolio moves at Royce International Premier Fund; the headline event is the fund's exit from JTC PLC rather than a Diploma-specific transaction, but the article is captured in the Diploma news feed by the source dataset. (https://finance.yahoo.com/news/royce-international-premier-fund-exits-210148171.html)
• 6 February 2026 — Why The Narrative Around Diploma (LSE:DPLM) Is Shifting As Price Targets Edge Higher (Simply Wall St.). Third-party valuation commentary; not summarised here per the no-analyst-opinion rule. (https://finance.yahoo.com/news/why-narrative-around-diploma-lse-012548673.html)
• 21 January 2026 — Why The Story Around Diploma (LSE:DPLM) Is Shifting With The Latest Price Target Update (Simply Wall St.). Third-party valuation commentary; not summarised here per the no-analyst-opinion rule. (https://finance.yahoo.com/news/why-story-around-diploma-lse-130738510.html)
• 20 January 2026 — Diploma (LON:DPLM) Is Doing The Right Things To Multiply Its Share Price (Simply Wall St.). Third-party analytical commentary on capital allocation and growth; not summarised here per the no-analyst-opinion rule. (https://finance.yahoo.com/news/diploma-lon-dplm-doing-things-123452968.html)
• 14 January 2026 — Diploma Q1 Earnings Call Highlights (MarketBeat). Diploma (LON:DPLM) reported a strong start to its financial year in a first-quarter trading update, with CEO Johnny Thomson highlighting "double-digit organic growth" and continued momentum on acquisitions. Speaking alongside newly promoted CFO Wilson, management said group organic growth for the quarter was double-digit. (https://www.marketbeat.com/instant-alerts/diploma-q1-earnings-call-highlights-2026-01-14/?utm_source=yahoofinance&utm_medium=yahoofinance)
• 4 January 2026 — Is Now The Time To Put Diploma (LON:DPLM) On Your Watchlist? (Simply Wall St.). Third-party watchlist commentary; not summarised here per the no-analyst-opinion rule. (https://finance.yahoo.com/news/now-time-put-diploma-lon-071721044.html)

The principal company-sourced events in the news flow are the 14 January 2026 Q1 FY2026 trading update (double-digit organic growth, CFO transition) and the 18 March 2026 FY2026 outlook upgrade (organic growth lifted to 6%–9%, operating margin lifted to 25%). The remaining entries are third-party analytical commentary, included here for completeness but not summarised per the no-analyst-opinion rule.

12. Key Dates Coming Up

Event	Date
Next earnings (H1 FY2026 interim results, expected)	19 May 2026
Most recent ex-dividend date in source data	15 January 2026
Dividend payment date	not disclosed in this report's source data
AGM date	not disclosed in this report's source data
Most recent management trading update	18 March 2026 (FY2026 outlook upgrade conference call)
Most recent quarterly trading update	14 January 2026 (Q1 FY2026 trading update)

---

Related ChartsView links: Live charts · Economic calendar · Forum · Blog

Disclaimer: This research note is for general information only and does not constitute investment advice, an offer to buy or sell any security, or a personalised recommendation. Figures are drawn from Diploma plc's own reported data as captured in the underlying dataset for this report; while we have taken care to attribute numerical claims to their source, no guarantee of accuracy is given. Markets are volatile, and past performance is not a reliable indicator of future results. Always consult a qualified financial adviser before making investment decisions.